Carregant...
Antiplatelet Therapy in Acute Coronary Syndrome
Antiplatelet agents have for decades been used to improve outcomes in patients with acute coronary syndromes and have become increasingly valued, not only for their antithrombotic properties but also for their anti-inflammatory effects. The drug class continues to evolve as novel agents with increas...
Guardat en:
| Publicat a: | Eur Cardiol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Radcliffe Cardiology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6206448/ https://ncbi.nlm.nih.gov/pubmed/30416549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2016:34:2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|